Filing Details

Accession Number:
0001209191-15-032711
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-06 17:23:13
Reporting Period:
2015-04-02
Filing Date:
2015-04-06
Accepted Time:
2015-04-06 17:23:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404281 Tokai Pharmaceuticals Inc TKAI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1618273 Lee Kalowski C/O Tokai Pharmaceuticals, Inc.
One Broadway, 14Th Floor
Cambridge MA 02142
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-04-02 2,258 $11.45 52,346 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold to satisfy certain tax obligations of the Reporting Person triggered by the vesting of certain restricted stock units. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.30 per share to $11.66 per share. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Represents 4,567 shares of common stock held by the Reporting Person and 47,779 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.